DSM Venturing

Corporate venture capital arm of dsm-firmenich, investing in early-stage health, nutrition, personal care, food, and beverage ingredients.

Corporate VC Active Heerlen, Netherlands Est. 2001
Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—

About

dsm-firmenich Ventures is the corporate venture capital arm of dsm-firmenich, founded in 2001. The firm invests in early-stage companies in health, nutrition, personal care, food, and beverage ingredients across North America, Europe, and Israel. They focus on startups that align with dsm-firmenich's innovation ambitions for their business units: Perfumery & Beauty, Taste, Texture & Health, and Health, Nutrition & Care. DSM Venturing supports entrepreneurs with financing, expertise, and technology, aiming for both commercial success and positive impact for people and the planet. They typically invest between €500k and €5m, taking minority ownership stakes (usually 5–25%), and can lead or follow investment rounds, preferring to syndicate deals.

Portfolio

No portfolio companies in this dataset yet.

Investment activity

2 portfolio exits on record.

Portfolio by sector

Agriculture & Food Technologies3
Energy Tech1
Health Tech & Life Sciences1

Q&A

What is DSM Venturing's primary investment focus by sector?
DSM Venturing shows a strong focus on Agriculture & Food Technologies, with 3 portfolio companies in this sector. They also have investments in Energy Tech and Health Tech & Life Sciences.
Can you name some of DSM Venturing's notable portfolio companies?
DSM Venturing's portfolio includes companies like Incredo, which focuses on flavor enhancement technology, and Meala Foodtech, which develops functional protein solutions for plant-based food applications.
Has DSM Venturing had any recent exits?
Yes, DSM Venturing had an exit in November 2022 when Raycatch, an AI-driven PV portfolio management company, was acquired by Bladeranger for $1.5M.
What is DSM Venturing's most recent investment activity?
DSM Venturing has been active recently, with investments in May 2023 and February 2023.
What is the typical investment stage for DSM Venturing?
DSM Venturing invests across various stages, including Pre-Seed, A Round, B Round, and C Round, with two investments at the C Round stage.
What is the nature of DSM Venturing's upcoming exit?
DSM Venturing is set to have an exit in September 2025 with Regentis Biomaterials, an implantable hydrogel platform for tissue regeneration, going public on NASDAQ.
What kind of companies does DSM Venturing typically invest in?
DSM Venturing primarily invests in B2B companies, such as Phytolon, which produces natural food colorants, and Incredo, focused on flavor enhancement technology.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

Identifiers & details

Founded2001